SCHEMBL3970922

SCHEMBL3970922

COc1cc2cc(Nc3cc(C)[nH]n3)nc(Cl)c2cc1C(=O)N(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 7/20 0.40
AURKB Q96GD4 5/20 0.40
PIK3C3 Q8NEB9 4/20 0.39
GSK3B P49841 2/20 0.39
LRRK2 Q5S007 2/20 0.39
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
RAB9A P51151 1/20 0.36
ATM Q13315 1/20 0.36
PAK4 O96013 2/20 0.36
JAK3 P52333 2/20 0.36
TYK2 P29597 1/20 0.36
PDE1A P54750 1/20 0.35
PDE1B Q01064 1/20 0.35
PDE3B Q13370 1/20 0.35
PDE1C Q14123 1/20 0.35
PDE3A Q14432 1/20 0.35
RET P07949 1/20 0.35
JAK1 P23458 1/20 0.35
PLK4 O00444 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3970804 0.89 AURKA (0.41) AURKAAURKBPIK3C3GSK3BLRRK2
SCHEMBL3968719 0.84 TTK (0.44) AURKAAURKBPIK3C3GSK3BLRRK2
SCHEMBL3967146 0.83 AURKA (0.43) AURKAAURKBPIK3C3GSK3BNPC1
SCHEMBL3967528 0.81 TTK (0.45) AURKAAURKBJAK3TYK2JAK1
SCHEMBL3968767 0.81 TTK (0.47) AURKAAURKBJAK3TYK2JAK1
SCHEMBL3970926 0.81 TTK (0.44) AURKAAURKBPIK3C3GSK3BLRRK2
SCHEMBL3967892 0.79 JAK2 (0.41) AURKAAURKBPIK3C3GSK3BNPC1
SCHEMBL3971328 0.79 AURKA (0.40) AURKAAURKBPIK3C3GSK3BNPC1
SCHEMBL3967909 0.77 AURKA (0.41) AURKAAURKBPIK3C3GSK3BPAK4
SCHEMBL3964609 0.76 AURKA (0.42) AURKAAURKBPIK3C3GSK3BGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7572809-B2 Isoquinoline aminopyrazole derivatives HOFFMANN-LA ROCHE INC. (US) 2009-08-11 US disclosed
US-7572809-B2 Isoquinoline aminopyrazole derivatives HOFFMANN-LA ROCHE INC. (US) 2009-08-11 US disclosed
EP-1966190-A1 ISOQUINOLINE AMINOPYRAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2008-09-10 EP disclosed
US-20070179151-A1 Isoquinoline aminopyrazole derivatives F. HOFMANN-LA ROCHE AG (CH) 2007-08-02 US disclosed
US-20070179151-A1 Isoquinoline aminopyrazole derivatives F. HOFMANN-LA ROCHE AG (CH) 2007-08-02 US disclosed
WO-2007071348-A1 ISOQUINOLINE AMINOPYRAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2007-06-28 WO disclosed
WO-2007071348-A1 ISOQUINOLINE AMINOPYRAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2007-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070179151-A1 Isoquinoline aminopyrazole derivatives CYP3A5, CYP3A43, CYP3A4 AURKA 1165/4885AURKB 1334/4885PIK3C3 1087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.